Lv3
336 积分 2024-03-29 加入
PROREPAIR-B: A Prospective Cohort Study of the Impact of Germline DNA Repair Mutations on the Outcomes of Patients With Metastatic Castration-Resistant Prostate Cancer
6小时前
已完结
Results after Four Years of Screening for Prostate Cancer with PSA and MRI
1天前
已完结
New Hormonal Agents in Patients With Nonmetastatic Castration-Resistant Prostate Cancer: Meta-Analysis of Efficacy and Safety Outcomes
7天前
已完结
Neurotoxicities of novel non-steroidal anti-androgens for prostate cancer: A systematic review and meta-analysis
7天前
已完结
Endocrine consequences of treatment with the new androgen receptor axis-targeted agents for advanced prostate cancer
7天前
已完结
Combining PARP Inhibitors and Androgen Receptor Signalling Inhibitors in Metastatic Prostate Cancer: A Quantitative Synthesis and Meta-analysis
12天前
已完结
Addition of Metastasis-Directed Therapy to Intermittent Hormone Therapy for Oligometastatic Prostate Cancer
12天前
已完结
Cancer and Leukemia Group B (CALGB) 90203: a randomized phase 3 study of radical prostatectomy alone versus estramustine and docetaxel before radical prostatectomy for patients with high-risk localized disease
12天前
已完结
Measuring response in metastatic castration-resistant prostate cancer using PSMA PET/CT: comparison of RECIST 1.1, aPCWG3, aPERCIST, PPP, and RECIP 1.0 criteria
18天前
已完结
Initial Experience with [177Lu]Lu-PSMA-617 After Regulatory Approval for Metastatic Castration-Resistant Prostate Cancer: Efficacy, Safety, and Outcome Prediction
18天前
已完结
皖公网安备34019202002308
